These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22789906)

  • 21. Progenitor cell-based treatment of glial disease.
    Goldman SA
    Prog Brain Res; 2017; 231():165-189. PubMed ID: 28554396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Connexin 43/47 channels are important for astrocyte/ oligodendrocyte cross-talk in myelination and demyelination.
    Basu R; Sarma JD
    J Biosci; 2018 Dec; 43(5):1055-1068. PubMed ID: 30541963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transgenic replacement of Cx32 in gap junction-deficient oligodendrocytes rescues the phenotype of a hypomyelinating leukodystrophy model.
    Schiza N; Sargiannidou I; Kagiava A; Karaiskos C; Nearchou M; Kleopa KA
    Hum Mol Genet; 2015 Apr; 24(7):2049-64. PubMed ID: 25524707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early disruption of glial communication via connexin gap junction in multiple sclerosis, Baló's disease and neuromyelitis optica.
    Masaki K
    Neuropathology; 2015 Oct; 35(5):469-80. PubMed ID: 26016402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myelination by transplanted fetal and neonatal oligodendrocytes in a dysmyelinating mutant.
    Friedman E; Nilaver G; Carmel P; Perlow M; Spatz L; Latov N
    Brain Res; 1986 Jul; 378(1):142-6. PubMed ID: 2427154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biology of oligodendrocyte and myelin in the mammalian central nervous system.
    Baumann N; Pham-Dinh D
    Physiol Rev; 2001 Apr; 81(2):871-927. PubMed ID: 11274346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Myelination, demyelination and re-myelination in the central nervous system].
    Graça DL
    Arq Neuropsiquiatr; 1988 Sep; 46(3):292-7. PubMed ID: 3066310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Connexin and pannexin hemichannels in inflammatory responses of glia and neurons.
    Bennett MV; Garré JM; Orellana JA; Bukauskas FF; Nedergaard M; Sáez JC
    Brain Res; 2012 Dec; 1487():3-15. PubMed ID: 22975435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoplasmic reticulum stress and the unfolded protein response in disorders of myelinating glia.
    Clayton BLL; Popko B
    Brain Res; 2016 Oct; 1648(Pt B):594-602. PubMed ID: 27055915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extensive loss of connexins in Baló's disease: evidence for an auto-antibody-independent astrocytopathy via impaired astrocyte-oligodendrocyte/myelin interaction.
    Masaki K; Suzuki SO; Matsushita T; Yonekawa T; Matsuoka T; Isobe N; Motomura K; Wu XM; Tabira T; Iwaki T; Kira J
    Acta Neuropathol; 2012 Jun; 123(6):887-900. PubMed ID: 22438105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene therapy approaches targeting Schwann cells for demyelinating neuropathies.
    Sargiannidou I; Kagiava A; Kleopa KA
    Brain Res; 2020 Feb; 1728():146572. PubMed ID: 31790684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The biology and pathobiology of Schwann cells.
    Scherer SS
    Curr Opin Neurol; 1997 Oct; 10(5):386-97. PubMed ID: 9330884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell-specific expression of connexins and evidence of restricted gap junctional coupling between glial cells and between neurons.
    Rash JE; Yasumura T; Dudek FE; Nagy JI
    J Neurosci; 2001 Mar; 21(6):1983-2000. PubMed ID: 11245683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transgenic expression of human connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null mice.
    Scherer SS; Xu YT; Messing A; Willecke K; Fischbeck KH; Jeng LJ
    J Neurosci; 2005 Feb; 25(6):1550-9. PubMed ID: 15703409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Olig2-lineage cells preferentially differentiate into oligodendrocytes but their processes degenerate at the chronic demyelinating stage of proteolipid protein-overexpressing mouse.
    Shimizu T; Tanaka KF; Takebayashi H; Higashi M; Wisesmith W; Ono K; Hitoshi S; Ikenaka K
    J Neurosci Res; 2013 Feb; 91(2):178-86. PubMed ID: 23172790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Four classes of intercellular channels between glial cells in the CNS.
    Altevogt BM; Paul DL
    J Neurosci; 2004 May; 24(18):4313-23. PubMed ID: 15128845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of remyelination: recent insight from experimental models.
    Tanaka T; Yoshida S
    Biomol Concepts; 2014 Aug; 5(4):289-98. PubMed ID: 25372760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coupling of astrocyte connexins Cx26, Cx30, Cx43 to oligodendrocyte Cx29, Cx32, Cx47: Implications from normal and connexin32 knockout mice.
    Nagy JI; Ionescu AV; Lynn BD; Rash JE
    Glia; 2003 Dec; 44(3):205-18. PubMed ID: 14603462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination.
    Brück W; Pförtner R; Pham T; Zhang J; Hayardeny L; Piryatinsky V; Hanisch UK; Regen T; van Rossum D; Brakelmann L; Hagemeier K; Kuhlmann T; Stadelmann C; John GR; Kramann N; Wegner C
    Acta Neuropathol; 2012 Sep; 124(3):411-24. PubMed ID: 22766690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic expression of Cx47 in mouse brain development and in the cuprizone model of myelin plasticity.
    Parenti R; Cicirata F; Zappalà A; Catania A; La Delia F; Cicirata V; Tress O; Willecke K
    Glia; 2010 Oct; 58(13):1594-609. PubMed ID: 20578039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.